Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
American Journal of Medical Genetics|September 12, 2000
Segregation of a pure form of spastic paraplegia and NOR insertion into Xq11.2A Tamagaki, M Shima, R Tomita, et al.
The Japanese Journal of Physiology|March 21, 1998
The differential involvement of von Willebrand factor, fibrinogen and fibronectin in acute experimental thrombosis in rat cerebral and mesenteric microvesselsJ Yamamoto, I Ishii, N Okita, et al.
Plos Biology|May 2, 2008
High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological statesKevin A Wilkinson, Robert J Gorelick, Suzy M Vasa, et al.
Journal of Vascular Surgery|September 6, 2006
The influence of inflation rate on the hematologic and hemodynamic effects of intermittent pneumatic calf compression for deep vein thrombosis prophylaxisRhys J Morris, John C Giddings, Heather M Ralis, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Factor IX inhibition and epitope localization of factor IX inhibitor antibodies in haemophilia B patients with anaphylactoid reactionsM Yamamoto, S Kamisue, Y Sawamoto, et al.
Thrombosis and Haemostasis|June 12, 1999
Identification of the binding site for an alloantibody to von Willebrand factor which inhibits binding to glycoprotein Ib within the amino-terminal region flanking the A1 domainM Shibata, M Shima, Y Fujimura, et al.
Nucleic Acids Research|January 11, 2000
RECODE: a database of frameshifting, bypassing and codon redefinition utilized for gene expressionP V Baranov, O L Gurvich, O Fayet, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 11, 2009
Impaired endothelial function may be due to decreased aortic tetrahydrobiopterin, assessed by a new flow-mediated vasodilation in vivo in hypercholesterolemic/atherogenic miceYukinori Tamura, Aki Naemura, Ayumi Inoue, et al.
Blood|February 7, 2001
Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C-mediated proteolysisK Nogami, M Shima, J C Giddings, et al.
British Journal of Haematology|October 16, 1999
Identification of a factor VIII peptide, residues 2315-2330, which neutralizes human factor VIII C2 inhibitor alloantibodies: requirement of Cys2326 and Glu2327 for maximum effectK Nogami, M Shima, H Nakai, et al.
Pageof 17